Tag: "nsaids" at biology news

Combining NSAIDs with chemotherapy, radiation may improve cancer treatment

... However, certain NSAIDs may be better suited to treating cancer, in combination with standard therapies, rather than preventing it, according to new research by scientists at the University of Iowa Roy J. and Lucille A. Carver Col...

NSAIDs modulate biomarker panel for esophageal adenocarcinoma

... ... A study of 243 patients with Barretts esophagus followed up for 10 years by Patricia Galipeau and colleagues from...

Activated vitamin D and NSAIDs form one-two punch against prostate cancer cells

PHILADELPHIA Low doses of the active form of vitamin D and non-steroidal anti-inflammatory drugs, taken in combination, have been shown to act as a powerful one-two punch that knocks down the growth of prostate cancer cells....... In a study published in the journal "Cancer Research", scientists from Stanford University discovered that the amount of both -- activated vitamin D, or calcitriol, an...

Clincal trials indicate NEXIUM can reduce upper GI symptoms in patients using NSAIDS

WILMINGTON, DE, May 12, 2005 Results from two clinical trials, published in the American Journal of Gastroenterology, demonstrate that NEXIUM (esomeprazole magnesium) can reduce upper gastrointestinal (GI) symptoms such as moderate to severe pain, burning and discomfort in the upper abdomen associated with continuous, daily use of non-steroidal anti-inflammatory drugs (NSAIDs), including select...

NSAIDs provoke a specific portfolio

Anaheim, Calif. -- Taking celecoxib, a COX-2 inhibitor better known as Celebrex, has been found to alter a specific "signature" set of genes in the colons of patients at high risk for a hereditary form of colon cancer, according to a new study reported here at the 96th Annual Meeting of the American Association for Cancer Research.... ...The scientists further reported that many of the genes, who...

NSAIDs cut risk of oral cancer among smokers

Anaheim, Calif. -- People who chose to light up cigarettes may want to take nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen as well, according to research reported here at the 96th Annual Meeting of the American Association for Cancer Research today.... ..."The use of NSAIDs among smokers protected against oral cancer development," said Jon Sudb, M.D., Ph.D., D.D.S., a...

Use of aspirin or other NSAIDs increases survival

Regular use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) seems to reduce the risk of developing various cancers, including prostate cancer. Now it appears that such drugs may help men with prostate cancer live longer, according to a Fox Chase Cancer Center study presented today at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology in Atla...
(Date:2/18/2015)... SUNNYVALE, Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... be speaking at the following conferences, and invited investors to ... Conference, Boston, MA Tuesday, March 3, ... Institutional Investors Conference, Orlando, FL Wednesday, ... Accessing Live Webcasts To access the live webcasts for these ...
(Date:2/12/2015)... Conn. , Feb. 12, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62/113114 for DISTRIBUTED ... DEVICES. The patent further establishes NXT-ID,s position ... its intellectual property portfolio the ability for multiple devices ...
(Date:2/9/2015)... -- Lintec of America recently announced an exclusive license to ... including sheets, yarns and ribbons, developed at the University ... vast industrial resources of the global Lintec Group, headquartered ... America is forming the Nano-Science and Technology Center (NSTC) ... scaling up the manufacturing and commercialization of nano engineered ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
Other Tags
renewabledifficultiesdyslexicsfacestranscriptomecollaboratingsolexapxlreversedfeetbasketballestablishingimplementationpredictedcoalrights